Associated Papers
Identification of DHX40 as a candidate susceptibility gene for colorectal and hematological neoplasia.
Olkinuora A et al.
Leukemia, 2023
37696923 (PubMed )
Supplement: 41375_2023_2021_MOESM11_ESM.xlsx › Table_S6
Salivary gland cancer organoids are valid for preclinical genotype-oriented medical precision trials.
Ishikawa T et al.
Iscience, 2023
37207275 (PubMed )
Supplement: mmc6.xlsx › Sheet1
Systematic analysis of the intersection of disease mutations with protein modifications.
Simpson CM et al.
Bmc Medical Genomics, 2019
31345222 (PubMed )
Supplement: 12920_2019_543_MOESM2_ESM.xlsx › S2
Cancer driver mutation prediction through Bayesian integration of multi-omic data.
Wang Z et al.
Plos One, 2018
The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.
Garofalo A et al.
Genome Medicine, 2016
27460824 (PubMed )
Supplement: 13073_2016_333_MOESM4_ESM.xlsx › all_matched_muts.maf
Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.
Esteban-Jurado C et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2015
Bioinformatics analysis of thousands of TCGA tumors to determine the involvement of epigenetic regulators in human cancer.
Gnad F et al.
Bmc Genomics, 2015
26110843 (PubMed )
Supplement: 1471-2164-16-S8-S5-S7.xls › RecurrentMutations
Age-related mutations associated with clonal hematopoietic expansion and malignancies.
Xie M et al.
Nature Medicine, 2014
25326804 (PubMed )
Supplement: NIHMS630249-supplement-7.xlsx › supplementaryTable3b.txt
RNA helicase A is a downstream mediator of KIF1Bβ tumor-suppressor function in neuroblastoma.
Chen ZX et al.
Cancer Discovery, 2014
24469107 (PubMed )
Supplement: 21598290cd130362-sup-table_s5.pdf
Select a paper to view details